Marc M. Oshiro

4.1k total citations · 2 hit papers
24 papers, 3.4k citations indexed

About

Marc M. Oshiro is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Marc M. Oshiro has authored 24 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Marc M. Oshiro's work include Epigenetics and DNA Methylation (13 papers), Cytokine Signaling Pathways and Interactions (5 papers) and Cancer-related Molecular Pathways (4 papers). Marc M. Oshiro is often cited by papers focused on Epigenetics and DNA Methylation (13 papers), Cytokine Signaling Pathways and Interactions (5 papers) and Cancer-related Molecular Pathways (4 papers). Marc M. Oshiro collaborates with scholars based in United States, Czechia and Spain. Marc M. Oshiro's co-authors include William S. Dalton, Richard Jove, Robyn Catlett-Falcone, James Turkson, Bernard W. Futscher, Terry H. Landowski, Lynn C. Moscinski, Gabriel Núñez, Alexander Levitzki and José L. Fernández-Luna and has published in prestigious journals such as Journal of Clinical Investigation, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Marc M. Oshiro

24 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells

1999 1.4k citations Robyn Catlett-Falcone, Terry H. Landowski et al. Immunity profile →
Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression

2001 505 citations Pearlie K. Epling‐Burnette, Jin Hong Liu et al. Journal of Clinical Investigation profile →

Peers

Countries citing papers authored by Marc M. Oshiro

Since Specialization

Citations

This map shows the geographic impact of Marc M. Oshiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc M. Oshiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc M. Oshiro more than expected).

Fields of papers citing papers by Marc M. Oshiro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc M. Oshiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc M. Oshiro. The network helps show where Marc M. Oshiro may publish in the future.

Co-authorship network of co-authors of Marc M. Oshiro

This figure shows the co-authorship network connecting the top 25 collaborators of Marc M. Oshiro. A scholar is included among the top collaborators of Marc M. Oshiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc M. Oshiro. Marc M. Oshiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cell-free DNA methylation analysis as a marker of malignancy in pleural fluid 2024 ·Scientific Reports ·Billie Bixby, Lukáš Vrba, (unknown), Marc M. Oshiro, George S. Watts, Trina Hughes, Heidi L. Erickson, Madhav Chopra, James Knepler, Kenneth S. Knox, (unknown), Raed Alalawi, Mrinalini Kala, (unknown), (unknown), Denise J. Roe, Linda L. Garland, Bernard W. Futscher, Mark A. Nelson	3
2	Liquid biopsy, using a novel DNA methylation signature, distinguishes pancreatic adenocarcinoma from benign pancreatic disease 2022 ·Clinical Epigenetics ·Lukáš Vrba, Bernard W. Futscher, Marc M. Oshiro, (unknown), (unknown), Charles Hu, (unknown), (unknown), (unknown), Hemanth Gavini, Denise J. Roe, Rachna T. Shroff, Mark A. Nelson	15
3	Detection of pancreatic cancer using a novel blood-based DNA methylation signature. 2020 ·Journal of Clinical Oncology ·(unknown), (unknown), Lukáš Vrba, Marc M. Oshiro, Betsy C. Wertheim, Denise J. Roe, Hemanth Gavini, (unknown), (unknown), (unknown), Hani M. Babiker, Emad Elquza, Aaron J. Scott, Mark A. Nelson, Bernard W. Futscher, Rachna T. Shroff	1
4	DNA methylation biomarkers discovered in silico detect cancer in liquid biopsies from non-small cell lung cancer patients 2019 ·Epigenetics ·Lukáš Vrba, Marc M. Oshiro, Samuel S. Kim, Linda L. Garland, (unknown), Daruka Mahadevan, Mark A. Nelson, Bernard W. Futscher	28
5	Agglomerative Epigenetic Aberrations Are a Common Event in Human Breast Cancer 2008 ·Cancer Research ·Petr Novák, Taylor J. Jensen, Marc M. Oshiro, George S. Watts, Christina J. Kim, Bernard W. Futscher	122
6	Different Mutant/Wild-Type p53 Combinations Cause a Spectrum of Increased Invasive Potential in Nonmalignant Immortalized Human Mammary Epithelial Cells 2008 ·Neoplasia ·Damian J. Junk, Lukáš Vrba, George S. Watts, Marc M. Oshiro, Jesse D. Martinez, Bernard W. Futscher	56
7	Epigenetic Inactivation of the HOXA Gene Cluster in Breast Cancer 2006 ·Cancer Research ·Petr Novák, Taylor J. Jensen, Marc M. Oshiro, Ryan J. Wozniak, Marcela Nouzová, George S. Watts, Walter T. Klimecki, Christina Kim, Bernard W. Futscher	86
8	AP-2α and AP-2γ are transcriptional targets of p53 in human breast carcinoma cells 2006 ·Oncogene ·(unknown), George S. Watts, Marc M. Oshiro, Bernard W. Futscher, Frederick E. Domann	26
9	Epigenetic silencing of DSC3 is a common event in human breast cancer 2005 ·Breast Cancer Research ·Marc M. Oshiro, Christina J. Kim, Ryan J. Wozniak, Damian J. Junk, José L. Muñoz-Rodríguez, Jeanne A. Burr, Matthew P. Fitzgerald, (unknown), Anne E. Cress, Frederick E. Domann, Bernard W. Futscher	92
10	The Acetyltransferase p300/CBP-Associated Factor Is a p53 Target Gene in Breast Tumor Cells 2004 ·Neoplasia ·George S. Watts, Marc M. Oshiro, Damian J. Junk, Ryan J. Wozniak, (unknown), Frederick E. Domann, Bernard W. Futscher	36
11	Epigenomic Changes during Leukemia Cell Differentiation: Analysis of Histone Acetylation and Cytosine Methylation Using CpG Island Microarrays 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Marcela Nouzová, (unknown), Marc M. Oshiro, R. Benjamin Isett, José L. Muñoz-Rodríguez, Alan F. List, Martha L. Narro, S.J. Miller, Nirav Merchant, Bernard W. Futscher	60
12	The Acetyltransferase p300/CBP-Associated Factor Is a p53 Target Gene in Breast Tumor Cells 2004 ·Neoplasia ·George S. Watts, Marc M. Oshiro, Damian J. Junk, Ryan J. Wozniak, (unknown), Frederick E. Domann, Bernard W. Futscher	33
13	Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression 2003 ·Oncogene ·Marc M. Oshiro, George S. Watts, Ryan J. Wozniak, Damian J. Junk, José L. Muñoz-Rodríguez, Frederick E. Domann, Bernard W. Futscher	79
14	The farnesyl transferase inhibitor, FTI-277, inhibits growth and induces apoptosis in drug-resistant myeloma tumor cells 2003 ·Leukemia ·Sophia C.E. Bolick, (unknown), David Boulware, Marc M. Oshiro, Junko Ohkanda, Andrew D. Hamilton, Saı̈d M. Sebti, William S. Dalton	60
15	Human Pancreatic Carcinoma Cells Activate Maspin Expression Through Loss of Epigenetic Control 2003 ·Neoplasia ·Matthew P. Fitzgerald, Marc M. Oshiro, (unknown), Kimberly J. Krager, Joseph J. Cullen, Bernard W. Futscher, Frederick E. Domann	40
16	Role for DNA methylation in the control of cell type–specific maspin expression 2002 ·Nature Genetics ·Bernard W. Futscher, Marc M. Oshiro, Ryan J. Wozniak, (unknown), Christin L. Hanigan, Hong Duan, Frederick E. Domann	347
17	Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression breakdown → 2001 ·Journal of Clinical Investigation ·Pearlie K. Epling‐Burnette, Jin Hong Liu, Robyn Catlett-Falcone, James Turkson, Marc M. Oshiro, Ravi Kothapalli, Yongxiang Li, Ju‐Ming Wang, Hsin‐Fang Yang‐Yen, James G. Karras, Richard Jove, Thomas P. Loughran	505
18	Inhibition of JAK kinase activity enhances Fas-mediated apoptosis but reduces cytotoxic activity of topoisomerase II inhibitors in U266 myeloma cells. 2001 ·PubMed ·Marc M. Oshiro, (unknown), Robyn Catlett-Falcone, Lori Hazlehurst, Mei Huang, Richard Jove, William S. Dalton	39
19	Ascorbic acid enhances arsenic trioxide–induced cytotoxicity in multiple myeloma cells 2001 ·Blood ·Jennifer M. Grad, Nizar J. Bahlis, Isildinha Reis, Marc M. Oshiro, William S. Dalton, Lawrence Boise	234
20	Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells breakdown → 1999 ·Immunity ·Robyn Catlett-Falcone, Terry H. Landowski, Marc M. Oshiro, James Turkson, Alexander Levitzki, Rocco Savino, Gennaro Ciliberto, Lynn C. Moscinski, José L. Fernández-Luna, Gabriel Núñez, William S. Dalton, Richard Jove	1408

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact